Lorem ipsum
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor Read More
Jul 20, 2023
Premio ABOUTPHARMA
Al Talent Garden di Milano sono stati premiati Msd, Janssen, Sanofi, Healthcare Network Partners, Astrazeneca, Pfizer, Mosaic Software, Angelini, Zoetis, Merck, Medtronic, Vivisol, Novartis e Baxter. ...
Ospedale in fiera per visite post Covid
La seconda vita dell'Ospedale in fiera. Da una parte lo abbiamo visto un'ala con le vaccinazioni per i bambini. DalL'altra un'intero presidio per le visite agli ex pazienti ricoverati di covid, ora guariti....
Come and see our products RESMON PRO FULL and DIARY at the next ERS 2018 annual conference in Paris!
We are proud to announce that both our product RESMON PRO FULL and DIARY will be present at the next ERS 2018 Annual Conference that will be held in Paris from the 15th to the 18th of September 2018. The products will be displayed at the booths of our international...
A new paper on the use of RESMON PRO FULL to evaluate the effects of airway clearance on patients with cystic fibrosis is available online!
Prof Wallaert and its research group in Belgium used the RESMON PRO FULL to investigate the effects of autogenic drainage technique on ventilatory mechanics in adult with cystic fibrosis. According to the authors: "The FOT opens up new avenues of mechanistic...
ERCA-JIVD 2018 Satellite Symposium: New Non-invasive COPD Screening of EFL Within Home Therapy now available online!
During this satellite symposium, held at the latest ERCA (European Respiratory Care Association) and JIVD (Journées Internationales de Ventilation à Domicile) congress, Prof. Peter Calverley, Prof. Raffaele Dellacà, dr. Romano and prof. David White will walk you...
Restech announces the clinical validation of the RESMON PRO DIARY to remotely monitor COPD at home.
The CHROMED trial, one of the largest clinical trial using FOT to monitor remotely COPD patients and prevent exacerbation has now been published on the American Journal of Respiratory and Critical care medicine! Using the RESMON PRO DIARY (the home version of the...
RESTECH will be present at the next screening day organized by the Italian League against Tumor (LILT)
Saturday 23rd of September 2017 RESTECH will participate with 2 RESMON PRO FULL devices to the "Spirometry day" organized by the Italian League against Tumor (LILT) in Bolzano. Anyone interested in having a free screening of his/her lung function can come and visit...
RESMON PRO FULL and DIARY at the annual ERS conference in Milan
RESTECH will be present at the next European Respiratory Society annual congress in Milan with both its products. RESMON PRO FULL will be presented at the booth of our distributor MGCDiagnostic (Hall 3, Stand 03). RESMON PRO DIARY will be exhibited by...
RESTECH and VIVISOL together to bring innovative monitoring at home of COPD patients
RESTECH srl and VIVISOL has established a long-term commercial partnership to commercialize the RESMON PRO DIARY and its innovative algorithm for the detection of the risk of exacerbation in COPD patients. Thanks to this collaboration RESTECH will be able to...
RESMON PRO FULL win the ERS POINT award 2016
RESMON PRO FULL has been awarded, between 18 nominees, by the European Respiratory Society with the POINT (Product of Outstanding Interest) award in the category of "Diagnostic Devices". Three were the reasons why the award was assigned: 1) it has a "simple"...
RESMON PRO FULL received 510(K) clearance from U.S. FDA
RESMON PFO FULL device has been approved by the U.S. Food and Drug Administration and it is now available in the U.S. through our distributor...
CHROMED trial completed successfully
Restech, in its role of technical manager and together with all the partner of the project, successfully concluded the CHROMED trial. With 312 patients enrolled and studied for 9 months by 6 clinical centers in 5 EU Countries, CHROMED has been the largest...
